Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2411784Generated: October 31, 2026

(4-Bromophenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone → 1-{4-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-5,5-dimethylimidazolidin-2-one

https://huagongshe.com/reaction/2411784

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(4-Bromophenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanoneHCID 71252046—
Reactant1-(4-Methoxybenzyl)-4,4-dimethylimidazolidin-2-oneHCID 71252673—
Reactant3-{4-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-1-(4-methoxybenzyl)-4,4-dimethylimidazolidin-2-oneHCID 71252876—
Product1-{4-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-5,5-dimethylimidazolidin-2-oneHCID 71252259—

Reaction Steps

Using (4-bromophenyl) [4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (150 mg) described in Preparation Example 165 and 1-(4-methoxybenzyl)-4,4-dimethylimidazolidin-2-one (112 mg) described in Preparation Example 54 and by the reaction and treatment in the same manner as in Example 426, the title compound (57 mg) was obtained via 3-{4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-1-(4-methoxybenzyl)-4,4-dimethylimidazolidin-2-one.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08816079B2
Source datasetuspto-grants-2014_08
ORD IDord-6a7b636f5f004c2eabf23692b90f21ac
Source noteuspto-grants-2014_08